CompaniesByCap
VTGN
VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare

VistaGen Therapeutics Inc. Income Statement 2011–2025

Income StatementBalance SheetCash Flow
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2018Mar 2017Mar 2016Mar 2013Mar 2012Mar 2011
Revenues
Revenue486,0001.1M-227,0001.1M1.1M001.3M0200,4001.3M2.1M
Gross Profit
Profitability
Operating Income-56.0M-33.0M-59.3M-47.8M-17.9M-20.8M-14.2M-10.2M-17.9M-6.8M-9.0M-6.6M
EBITDA
Net Income-51.4M-29.4M-59.2M-47.8M-17.9M-20.8M-14.3M-10.3M-47.2M-12.9M-12.2M-9.5M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)31M19M7M2M18M15M5M

VistaGen Therapeutics Inc. Income Statement — FAQ

VistaGen Therapeutics Inc. (VTGN) income statement over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VTGN's income statement history?

The chart and table above show VistaGen Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.